Enzo Biochem
ENZ was delisted on the 17th of April, 2025.
100 hedge funds and large institutions have $101M invested in Enzo Biochem in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 9 closing their positions.
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
60% more call options, than puts
Call options by funds: $481K | Put options by funds: $300K
25% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 24
12% more funds holding
Funds holding: 89 → 100 (+11)
9% more capital inflows, than outflows
Capital inflows: $11.5M | Capital outflows: $10.5M
0.58% more ownership
Funds ownership: 47.57% → 48.15% (+0.58%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.47M |
| 2 |
Renaissance Technologies
New York
|
+$876K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$708K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$673K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$541K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Light Asset Management
Edina,
Minnesota
|
-$2.48M |
| 2 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$2.27M |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$965K |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$665K |
| 5 |
BCM
Breithorn Capital Management
New York
|
-$633K |
ENZ Hedge Fund Activity: Q1 2016 in Review
100 of the 3,768 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem (ENZ) for Q1 2016, worth a combined $101M — up 2.2% from $98.6M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ENZ positions and 9 closed out — a net gain of 10 holders — while 30 added to existing stakes and 24 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $3.47M. The largest seller was First Light Asset Management, cutting an estimated $2.48M.
- 100 institutional investors held Enzo Biochem (ENZ) as of Q1 2016, up from 89 in Q4 2015.
- Funds reported $101M of Enzo Biochem stock for Q1 2016, up 2.2% quarter-over-quarter.
- 19 funds opened new Enzo Biochem positions in Q1 2016 and 9 closed out, a net change of +10 holders.
- The largest Enzo Biochem buyer in Q1 2016 was Acadian Asset Management, an estimated $3.47M added.
- The largest Enzo Biochem seller in Q1 2016 was First Light Asset Management, an estimated $2.48M sold.
Based on aggregated 13F filings for Q1 2016.